ArticleClinical transplantation2026
Center Differences in PreTransplant Functional Status and Its Association With Survival After Heart Transplantation.
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Karnofsky Performance Scale (KPS) is widely used to assess functional status in heart transplantation (HT) candidates and inform risk stratification. However, its subjective nature raises questions about the consistency and prognostic value of KPS scoring across centers.
methodsWe analyzed adult patients undergoing first-time single-organ HT from November 2018 to June 2024 in the United Network for Organ Sharing database. Patients with prior transplants, multi-organ transplants, missing data, or loss to follow-up before 1 year were excluded. KPS at transplantation was analyzed continuously and categorized as low (0-30), medium (40-70), or high (80-100). Hierarchical linear and logistic regression models with center-level random effects were used to assess variability in KPS assignment and the association between KPS and 1-year posttransplant mortality.
resultsAmong 13 726 patients, median KPS at transplantation was 30 (IQR 20-50), and 60% were in the low range. Adjusted hierarchical linear models showed 28% (95% CI 22%-33%) of KPS variance was attributable to differences between centers. KPS was not associated with 1-year mortality (OR 1.00, 95% CI 0.99-1.00; p = 0.564), and no between-center heterogeneity in this association was detected.
conclusionKPS exhibits substantial center-level variability and is not associated with 1-year mortality in heart transplantation, suggesting caution in using KPS for short-term risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.